We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Spire Healthcare Group plc (SPI) Ordinary 1p

Sell:240.50p Buy:241.00p 0 Change: 1.00p (0.41%)
FTSE 250:0.07%
Market closed Prices as at close on 12 July 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Change: 1.00p (0.41%)
Market closed Prices as at close on 12 July 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Change: 1.00p (0.41%)
Market closed Prices as at close on 12 July 2024 Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Spire Healthcare Group plc is a United Kingdom-based company that owns and operates private hospitals and clinics in the United Kingdom and provides a range of private healthcare services. The Company offers a range of treatments and services, such as allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, dental surgery, ear, nose and throat, eye surgery and treatments, family planning, gastroenterology, general medicine, general surgery, hematology, hand surgery, heart treatments, hip and knee, kidney treatments, men's health, neurosurgery and neurology, pediatrics, physiotherapy, podiatry, skin treatments, spinal surgery and treatments, sports science, urology, vascular surgery, weight loss, and women's health. Its tests and scans include cardiac computerized tomography (CT), CT scans, magnetic resonance imaging (MRI) scans, ultrasound scans, and x-rays.

Contact details

3 Dorset Rise
United Kingdom
+ (0)

Important dates

Future events
Interim results 12 September 2024 12/09/24
Past events
Final dividend payment date 21 June 2024 21/06/24
Final ex-dividend date 23 May 2024 23/05/24
AGM 09 May 2024 09/05/24
Trading Announcement 09 May 2024 09/05/24
Final results 29 February 2024 29/02/24
Interim results 14 September 2023 14/09/23

General stock information

Market cap:
£969.17 million
Shares in issue:
403.82 million
Health Care Equipment & Services
London Stock Exchange
Sterling pence
FTSE 250,FTSE 350,FTSE All Share

Key personnel

  • Justinian Ash
    Chief Executive Officer, Executive Director
  • Harbant Samra
    Chief Financial Officer, Executive Director
  • John Forrest
    Chief Operating Officer
  • Mantraraj Budhdev
    Group General Counsel, Corporate Concerns Director
  • Cathy Cale
    Group Medical Director
  • Peter Corfield
    Chief Commercial Officer
  • Lisa Grant
    Group Clinical Director, Chief Nurse
  • Rachel King
    Group People Director
  • Philip Davies
    Company Secretary

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by NBTrader.

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.